RCS - Fevara PLC - Notice of Investor Presentation

FevaraAnnouncement

Mon 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260413:nRSM0246Aa&default-theme=true

RNS Number : 0246A  Fevara PLC  13 April 2026

13 April 2026

Fevara plc

("Fevara", the "Company" or the "Group")

Notice of Investor Presentation

Fevara plc (LSE: FVA), an international specialist in livestock supplements,
will host a live presentation for investors in respect of the Company's
results for the six months ended 28 February 2026.

Joshua Hoopes, Chief Executive Officer and Gavin Manson, Chief Financial
Officer, will provide a live presentation via the Engage Investor platform at
11.00am BST on Friday 24 April 2026.

Fevara PLC welcomes all current shareholders and interested investors to join
and encourages investors to pre-submit questions. Investors can also submit
questions at any time during the live presentation. Investors can sign up to
Engage Investor at no cost and follow Fevara PLC from their personalised
investor hub.

Register your interest in this event here:
https://engageinvestor.news/FVA_IP26 (https://engageinvestor.news/FVA_IP26)

 

- Ends -

For further information, please contact:

Enquiries

 Fevara plc                                      +44 (0) 1228 554 600
 Joshua Hoopes, Chief Executive Officer

 Gavin Manson, Chief Financial Officer

 Hudson Sandler                                  +44 (0) 20 7796 4133
 Hattie Dreyfus / Nick Moore / Francesca Rosser

 

About Fevara plc:

Fevara is an international specialist in livestock supplements.

 

Fevara's purpose is to empower farmers in extensive grazing systems with
research-proven products that boost profitability, improve resource efficiency
and support sustainable agriculture.  The Group develops, manufactures and
markets research-proven supplements, including feed licks, blocks, bagged
minerals, and boluses for cattle, sheep and horses, sold under recognised and
trusted brands, including Crystalyx®, Horslic®, Horslyx®, Scotmin
Nutrition®, SmartLic®, Tracesure® Advanced and Macal®.

 

Headquartered in Carlisle, Cumbria, in the UK, Fevara has six  manufacturing
sites in the UK, US and Brazil with three operational joint ventures in
Germany and the US. It serves customers in more than 20 countries through its
expansive international distribution and support network.

 

Fevara has been listed on the London Stock Exchange since 1972.

 

For more information, visit: www.fevara.com (http://www.fevara.com)

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAURARRNOUSAAR



            Copyright 2019 Regulatory News Service, all rights reserved